
Elli Peselev
Examiner (ID: 3791)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1203, 2899, 1621, 1623, 1803, 1673, 1802, 1211 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7061689
[patent_doc_number] => 20050004051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Methods for treatment of bacterial infections in impaired renal patients'
[patent_app_type] => utility
[patent_app_number] => 10/860723
[patent_app_country] => US
[patent_app_date] => 2004-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 32434
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004051.pdf
[firstpage_image] =>[orig_patent_app_number] => 10860723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/860723 | Methods for treatment of bacterial infections in impaired renal patients | Jun 1, 2004 | Abandoned |
Array
(
[id] => 5242864
[patent_doc_number] => 20070021359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Addition salts of azithromycin and citric acid and process for preparing them'
[patent_app_type] => utility
[patent_app_number] => 10/558801
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 2370
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021359.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558801 | Addition salts of azithromycin and citric acid and process for preparing them | May 25, 2004 | Abandoned |
Array
(
[id] => 7200060
[patent_doc_number] => 20050164958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'O-alkyl macrolide and azalide derivatives and regioselective process for their preparation'
[patent_app_type] => utility
[patent_app_number] => 10/851768
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5064
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164958.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851768
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851768 | O-alkyl macrolide and azalide derivatives and regioselective process for their preparation | May 20, 2004 | Issued |
Array
(
[id] => 7122887
[patent_doc_number] => 20050014716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Pancreatic cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 10/850936
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5905
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014716.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850936 | Pancreatic cancer treatment | May 19, 2004 | Abandoned |
Array
(
[id] => 7276311
[patent_doc_number] => 20040235762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Rapamycin carbohydrate derivatives'
[patent_app_type] => new
[patent_app_number] => 10/845747
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13924
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845747 | Rapamycin carbohydrate derivatives | May 12, 2004 | Issued |
Array
(
[id] => 5107666
[patent_doc_number] => 20070066544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => '3-Decladinosyl 9a-n-carbamoyl and 9a-n-thiocarbamoyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a'
[patent_app_type] => utility
[patent_app_number] => 10/557025
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14621
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066544.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557025 | 3-Decladinosyl 9a-n-carbamoyl and 9a-n-thiocarbamoyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a | May 10, 2004 | Abandoned |
Array
(
[id] => 5119562
[patent_doc_number] => 20070141276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Novel 14 and 15 membered ring compounds'
[patent_app_type] => utility
[patent_app_number] => 10/556706
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18931
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141276.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556706
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556706 | Novel 14 and 15 membered ring compounds | May 10, 2004 | Abandoned |
Array
(
[id] => 5259651
[patent_doc_number] => 20070213283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Macrolides substituted at the 4\"-position'
[patent_app_type] => utility
[patent_app_number] => 10/556381
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34539
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213283.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556381 | Macrolides substituted at the 4"-position | May 10, 2004 | Abandoned |
Array
(
[id] => 263785
[patent_doc_number] => 07569550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => '14 and 15 membered ring compounds'
[patent_app_type] => utility
[patent_app_number] => 10/556645
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28336
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569550.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556645
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556645 | 14 and 15 membered ring compounds | May 10, 2004 | Issued |
Array
(
[id] => 5231364
[patent_doc_number] => 20070293472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Novel 14 and 15 Membered Ring Compounds'
[patent_app_type] => utility
[patent_app_number] => 10/556708
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24306
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293472.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556708 | Novel 14 and 15 Membered Ring Compounds | May 10, 2004 | Abandoned |
Array
(
[id] => 7122878
[patent_doc_number] => 20050014707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => '6,11-4C-bicyclic 9a-azalide derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/840949
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23555
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014707.pdf
[firstpage_image] =>[orig_patent_app_number] => 10840949
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/840949 | 6,11-4C-bicyclic 9a-azalide derivatives | May 6, 2004 | Abandoned |
Array
(
[id] => 720558
[patent_doc_number] => 07049417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => '6,11-4-Carbon bridged ketolides'
[patent_app_type] => utility
[patent_app_number] => 10/841206
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19528
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049417.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841206
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841206 | 6,11-4-Carbon bridged ketolides | May 6, 2004 | Issued |
Array
(
[id] => 7089650
[patent_doc_number] => 20050009763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => '6,11-4-Carbon bridged erythromycin derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/841249
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19509
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009763.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841249
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841249 | 6,11-4-Carbon bridged erythromycin derivatives | May 6, 2004 | Abandoned |
Array
(
[id] => 7432515
[patent_doc_number] => 20040209827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => '11-C-substituted derivatives of clarithromycin'
[patent_app_type] => new
[patent_app_number] => 10/840986
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16928
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209827.pdf
[firstpage_image] =>[orig_patent_app_number] => 10840986
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/840986 | 11-C-substituted derivatives of clarithromycin | May 6, 2004 | Abandoned |
Array
(
[id] => 8968190
[patent_doc_number] => 08507000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-13
[patent_title] => 'Controlled release formulation of erythromycin derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/555849
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8259
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10555849
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555849 | Controlled release formulation of erythromycin derivatives | May 5, 2004 | Issued |
Array
(
[id] => 7061688
[patent_doc_number] => 20050004050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Dalbavancin compositions for treatment of bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 10/834395
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 32479
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004050.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834395 | Dalbavancin compositions for treatment of bacterial infections | Apr 26, 2004 | Issued |
Array
(
[id] => 7206048
[patent_doc_number] => 20050043223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility'
[patent_app_type] => utility
[patent_app_number] => 10/832965
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9619
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043223.pdf
[firstpage_image] =>[orig_patent_app_number] => 10832965
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/832965 | Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility | Apr 25, 2004 | Abandoned |
Array
(
[id] => 907286
[patent_doc_number] => 07332476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-19
[patent_title] => 'Pyridyl substituted ketolide antibiotics'
[patent_app_type] => utility
[patent_app_number] => 10/831749
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78173
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/332/07332476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831749
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831749 | Pyridyl substituted ketolide antibiotics | Apr 22, 2004 | Issued |
Array
(
[id] => 6983835
[patent_doc_number] => 20050153905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Novel ketolide derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/831522
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19910
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153905.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831522 | Ketolide derivatives | Apr 22, 2004 | Issued |
Array
(
[id] => 7318898
[patent_doc_number] => 20040224908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Stable compositions of dalbavancin'
[patent_app_type] => new
[patent_app_number] => 10/829068
[patent_app_country] => US
[patent_app_date] => 2004-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23222
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224908.pdf
[firstpage_image] =>[orig_patent_app_number] => 10829068
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/829068 | Stable compositions of dalbavancin | Apr 19, 2004 | Abandoned |